Hospira Potassium Chloride Recall: Particulate Hazard
Hospira recalls 255,900 vials of Potassium Chloride for Inj. Concentrate due to iron oxide particulates. Check your lot number immediately.
Stop using this now
Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
Contact the company
What happened, in plain English
Hospira Inc. is recalling Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vials intended for IV use. The recall was issued because red and black particulate matter, identified as iron oxide, was found within the solution and embedded in the plastic vial. This affects Lot 22-127-DK distributed nationwide. Read more at govinfonow.com/recall/46167-hospira-inc-recalls-potassium-chloride-for-inj-concentrate-usp-40.
Source Summary by GovInfoNow · govinfonow.com/recall/46167-hospira-inc-recalls-potassium-chloride-for-inj-concentrate-usp-40 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1261-2014
Cite this page
“Hospira Potassium Chloride Recall: Particulate Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46167-hospira-inc-recalls-potassium-chloride-for-inj-concentrate-usp-40. Based on FDA recall #D-1261-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1261-2014%22&limit=1).
Why it’s dangerous
The presence of foreign particulate matter (iron oxide) in an injectable solution poses a risk of embolism or other serious complications if the contaminated fluid is administered into a patient's bloodstream. The particles are visible as red and black specks within the vial.
Who’s affected
Patients receiving intravenous potassium chloride treatment and healthcare providers administering this specific medication are affected. The recall specifically targets units from Lot 22-127-DK.
How to tell if you have this one
Look for Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vials manufactured by Hospira, Inc. Check specifically for Lot number 22-127-DK. Visually inspect the solution for red and black particulate matter.
- Brand
Hospira- Category
Drug
What to do — step by step
Stop using the product
Do not administer or use any vials identified as part of the recalled lot due to the presence of foreign particulates.
Contact your supplier
Reach out to your pharmaceutical distributor or manufacturer for instructions on returning or disposing of the affected inventory.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many units are affected?
Approximately 255,900 vials are subject to this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1261-2014 (March 27, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1261-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.